Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuhiro Uchiba

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Hematology|January 5, 2021
Glycosylated ferritin as an improved marker for post-transfusion iron overloadAyako Ishihara, Tsuyuko Yamauchi, Katsuyoshi Ikeda, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 27, 2007
Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitroYuichiro Mizuochi, Kenji Okajima, Naoaki Harada, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2010
Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cellsMitsuhiro Uchiba, Takahisa Imamura, Hiroyuki Hata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma]Shikiko Ueno, Junko Nozaki, Shinichi Kusano, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 19, 2019
Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitorsRie Shirayama, Hideyuki Takedani, Yushi Chikasawa, et al.
International Journal of Hematology|March 17, 2016
Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroidsShiho Fujiwara, Hiromi Mochinaga, Hirotomo Nakata, et al.
Cancer Reports (Hoboken, N.J.)|November 27, 2025
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel ManufacturingTaichi Hirano, Hiro Tatetsu, Shikiko Ueno, et al.
Journal of Medical Case Reports|November 8, 2012
Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case reportYoshihiro Wada, Mitsuhiro Uchiba, Yoshiaki Kawano, et al.
Thrombosis Journal|March 16, 2017
A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~Daisuke Sueta, Miwa Ito, Mitsuhiro Uchiba, et al.
International Cancer Conference Journal|June 1, 2019
Acquired factor V deficiency following transcatheter arterial chemoembolization for hepatocellular carcinoma: a case reportTaishi Yamane, Katsunori Imai, Mitsuhiro Uchiba, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Hematology|January 5, 2021
Glycosylated ferritin as an improved marker for post-transfusion iron overloadAyako Ishihara, Tsuyuko Yamauchi, Katsuyoshi Ikeda, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 27, 2007
Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitroYuichiro Mizuochi, Kenji Okajima, Naoaki Harada, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2010
Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cellsMitsuhiro Uchiba, Takahisa Imamura, Hiroyuki Hata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 8, 2019
[Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma]Shikiko Ueno, Junko Nozaki, Shinichi Kusano, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 19, 2019
Perioperative safety and haematostatic efficacy of a new bypassing agent pd-FVIIa/FX (Byclot) in haemophilia patients with high-responding type inhibitorsRie Shirayama, Hideyuki Takedani, Yushi Chikasawa, et al.
International Journal of Hematology|March 17, 2016
Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroidsShiho Fujiwara, Hiromi Mochinaga, Hirotomo Nakata, et al.
Cancer Reports (Hoboken, N.J.)|November 27, 2025
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel ManufacturingTaichi Hirano, Hiro Tatetsu, Shikiko Ueno, et al.
Journal of Medical Case Reports|November 8, 2012
Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case reportYoshihiro Wada, Mitsuhiro Uchiba, Yoshiaki Kawano, et al.
Thrombosis Journal|March 16, 2017
A case of pulmonary thromboembolism due to coagulation factor V Leiden in Japan ~ usefulness of next generation sequencing~Daisuke Sueta, Miwa Ito, Mitsuhiro Uchiba, et al.
International Cancer Conference Journal|June 1, 2019
Acquired factor V deficiency following transcatheter arterial chemoembolization for hepatocellular carcinoma: a case reportTaishi Yamane, Katsunori Imai, Mitsuhiro Uchiba, et al.
Pageof 5